These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21131340)

  • 1. French doctors demand to know why drug stayed on the market for so long.
    Benkimoun P
    BMJ; 2010 Dec; 341():c6882. PubMed ID: 21131340
    [No Abstract]   [Full Text] [Related]  

  • 2. [What were the indications for the Mediator in 1979?].
    Nau JY
    Rev Med Suisse; 2011 Feb; 7(281):374-5. PubMed ID: 21416722
    [No Abstract]   [Full Text] [Related]  

  • 3. Licensing drugs for diabetes.
    Lehman R; Yudkin JS; Krumholz H
    BMJ; 2010 Sep; 341():c4805. PubMed ID: 20819887
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones?
    Freemantle N
    BMJ; 2010 Sep; 341():c4812. PubMed ID: 20819888
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosiglitazone: what went wrong?
    Cohen D
    BMJ; 2010 Sep; 341():c4848. PubMed ID: 20819889
    [No Abstract]   [Full Text] [Related]  

  • 6. Mediator scandal engulfs French compensation body.
    Mullard A
    Lancet; 2013 May; 381(9880):1803. PubMed ID: 23717833
    [No Abstract]   [Full Text] [Related]  

  • 7. France to prosecute its drug regulator and Servier in scandal over diabetes drug.
    Dyer O
    BMJ; 2017 Sep; 358():j4231. PubMed ID: 28893847
    [No Abstract]   [Full Text] [Related]  

  • 8. Mediator: who's to blame?
    Vincent L; Guardiola B; Tsouderos Y; Canet E
    Lancet; 2011 Jun; 377(9782):2003. PubMed ID: 21665033
    [No Abstract]   [Full Text] [Related]  

  • 9. Lessons from the Mediator scandal.
    Prescrire Int; 2011 Dec; 20(122):284. PubMed ID: 22216537
    [No Abstract]   [Full Text] [Related]  

  • 10. [Wrong choice of antidiabetics can be disastrous].
    Sjöholm A
    Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2300-1. PubMed ID: 20973243
    [No Abstract]   [Full Text] [Related]  

  • 11. Benfluorex: how many deaths?
    Prescrire Int; 2011 Feb; 20(113):45. PubMed ID: 21488593
    [No Abstract]   [Full Text] [Related]  

  • 12. In the wake of the Mediator scandal: some progress in France, but apathy at the European level.
    Prescrire Int; 2012 Apr; 21(126):110. PubMed ID: 22515143
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug scandal exposes French regulators to public ire.
    Casassus B
    Nat Med; 2011 Feb; 17(2):144. PubMed ID: 21297596
    [No Abstract]   [Full Text] [Related]  

  • 14. Bulletin campaigns against withdrawal of Mixtard 30.
    Hawkes N
    BMJ; 2010 Aug; 341():c4210. PubMed ID: 20685798
    [No Abstract]   [Full Text] [Related]  

  • 15. Mediator: who's to blame?
    Waller P; Evans S
    Lancet; 2011 Jun; 377(9782):2002-3. PubMed ID: 21665030
    [No Abstract]   [Full Text] [Related]  

  • 16. Mediator: who's to blame?
    Braillon A
    Lancet; 2011 Jun; 377(9782):2003-4. PubMed ID: 21665032
    [No Abstract]   [Full Text] [Related]  

  • 17. Exposure to benfluorex: left heart valve disease very common.
    Prescrire Int; 2013 Jul; 22(140):185. PubMed ID: 23951595
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical treatment of type 2 diabetes. French Agency for the Health Safety of Health Products].
    Diabetes Metab; 1999 Dec; 25(6):533-50. PubMed ID: 10633881
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosiglitazone and the need for a new drug safety agency.
    Garattini S; Bertele' V
    BMJ; 2010 Oct; 341():c5506. PubMed ID: 20926483
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosiglitazone, marketing, and medical science.
    Moynihan R
    BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.